What is the diagnostic flow chart for evaluating a patient with confirmed hypokalemia (<3.5 mEq/L)?

Diagnostic Flow Chart for Hypokalemia (<3.5 mEq/L)

Begin by measuring spot urine potassium-to-creatinine ratio (K/Cr) and assessing acid-base status to systematically determine the etiology of confirmed hypokalemia.

Initial Assessment

Step 1: Measure Spot Urine K/Cr Ratio

• K/Cr ratio <1.5: Suggests extrarenal losses (GI losses, poor intake, or transcellular shift)
• K/Cr ratio ≥1.5: Indicates renal potassium wasting 1, 2

Step 2: Assess Acid-Base Status

Simultaneously evaluate blood pH and bicarbonate to categorize the metabolic state.

---

Diagnostic Algorithm Based on K/Cr Ratio and Acid-Base Status

Branch A: K/Cr Ratio <1.5 (Extrarenal Losses)

With Metabolic Acidosis:

• Likely cause: Lower GI losses (diarrhea, laxative abuse) 1
• Action: Evaluate for diarrhea history, stool studies, laxative screen

With Metabolic Alkalosis + Normal Blood Pressure:

• Likely cause: Surreptitious vomiting 1
• Action: Measure spot urine chloride
  • Urine Cl⁻ <33.3 mmol/L: Strongly suggests vomiting (92% sensitivity, 95.1% specificity) 3
  • Serum Cl⁻ <94.9 mmol/L: Also highly suggestive of vomiting-related losses 3

With Paralysis:

• Consider: Hyperthyroidism, familial/sporadic periodic paralysis 1
• Action: Check TSH, thyroid hormones; genetic testing if indicated

---

Branch B: K/Cr Ratio ≥1.5 (Renal Potassium Wasting)

With Metabolic Acidosis:

• Likely causes: Diabetic ketoacidosis, Type 1 or Type 2 distal renal tubular acidosis 1
• Action: Check glucose, ketones, urine pH, urine anion gap

With Metabolic Alkalosis + Normal Blood Pressure:

• Likely causes: Diuretic use, Bartter syndrome, Gitelman syndrome 1
• Action:
  • Urine diuretic screen
  • Measure urine calcium (low in Gitelman, normal/high in Bartter)
  • Consider genetic testing if familial pattern

With Metabolic Alkalosis + Hypertension:

This is the critical branch requiring screening for secondary hypertension causes.

Screen for Primary Aldosteronism 4, 5, 6:

Indications for screening (any of the following):

• Spontaneous hypokalemia (K⁺ <3.5 mEq/L) in hypertensive patient
• Marked diuretic-induced hypokalemia (K⁺ <3.0 mEq/L)
• Hypertension resistant to 3 drugs
• Incidental adrenal adenoma with hypertension

Screening test:

• Measure plasma aldosterone concentration (PAC) and plasma renin activity (PRA) or direct renin 4, 5

Diagnostic confirmation 7, 6:

• If PAC >20 ng/dL (>550 pmol/L) with suppressed renin AND spontaneous hypokalemia: No further confirmatory testing needed—diagnosis established 7
• All other cases: Perform one or more confirmatory tests:
  • Oral sodium loading test (preferred for outpatient): 24-hour urine aldosterone <10 mcg/24h excludes PA 6
  • Captopril challenge test: Post-captopril aldosterone <10 ng/dL (immunoassay) or <7.5 ng/dL (LC-MS/MS) excludes PA 6
  • Saline suppression test: Post-infusion aldosterone <5.8 ng/dL (LC-MS/MS) or <7.8 ng/dL (immunoassay) excludes PA 6
  • Fludrocortisone suppression test

Critical caveat: Correct hypokalemia before confirmatory testing to avoid false-negative results 7, 6

Consider Other Causes:

• Cushing syndrome: Measure 24-hour urine free cortisol or late-night salivary cortisol
• Renovascular hypertension: If ≥2 clinical clues present 4, 5:
  • Age >55 or <30 years with sudden onset/worsening HTN
  • Abdominal bruit
  • Resistant to 3 drugs
  • Creatinine increase ≥30% with ACE-I/ARB
  • Other atherosclerotic disease
  • Recurrent pulmonary edema
• Congenital adrenal hyperplasia: 17-hydroxyprogesterone level
• Apparent mineralocorticoid excess: Urine cortisol/cortisone ratio
• Liddle syndrome: Clinical presentation, genetic testing

---

Additional Diagnostic Considerations

Check for Hypomagnesemia

• Measure serum magnesium in all hypokalemia cases
• Hypomagnesemia causes refractory hypokalemia through increased urinary potassium losses 1
• Must correct magnesium to successfully treat hypokalemia

Assess Severity for Urgent Treatment Needs

Urgent treatment indicated if 8:

• K⁺ ≤2.5 mEq/L
• ECG abnormalities (U waves, ST depression, T-wave flattening/inversion, QT prolongation) 9
• Neuromuscular symptoms (weakness, paralysis)

---

Common Pitfalls to Avoid

1. Do not rely on isolated urine potassium measurement—always calculate K/Cr ratio or fractional excretion 1, 2, 3

2. Do not screen for primary aldosteronism while patient is hypokalemic—correct potassium first to avoid false-negative results 7, 6

3. Do not assume hypokalemia rules out primary aldosteronism—most PA patients are normokalemic; hypokalemia is a late finding 10

4. Withdraw interfering medications before PA testing: Stop aldosterone antagonists 4-6 weeks prior, ACE-I/ARBs 2 weeks prior; use non-dihydropyridine calcium channel blockers, alpha-blockers, or hydralazine for BP control during testing 7

5. In normotensive patients with renal K⁺ wasting, measure spot urine chloride—this single test (cutoff <33.3 mmol/L) has 92% sensitivity and 95.1% specificity for vomiting-related hypokalemia 3